Sofiposte, a subsidiary of the French state postal network, has raised E50m to invest in post, financial services and express courier businesses.
Vivendi Universal has chosen US venture capital firm Global Asset Capital to take over its struggling Viventures unit.
The US life sciences investor has sold the hepatitis and HIV treatment company to Novartis in a deal that values the business at up to $612m.
The transatlantic general partner, which pursues a buy-and-build strategy in the business services sector, has held a final closing of its debut fund on $500m.
The UK bank will retain a near-20 per cent stake in Montagu Private Equity, which will remain the bank’s primary vehicle for European private equity investment.
Now that prospective investors in private equity funds are approaching the due diligence process with the same rigour as GPs have applied to target portfolio companies, there are some important infrastructure issues a GP has to address. Steven Millner of DML looks at what a GP has to do to make sure an LP is going to be satisfied.
CDC Ixis leads E10m photonics round; VC Strathdon raises further £2m; Cazenove backs Empower Interactive; European VCs complete Kaidara E8m round
Carlyle, Bain Capital and Texas Pacific have reportedly joined forces to back oil billionaire Marvin Davis in his pursuit of Vivendi’s US media assets.
Kurt Björklund is to head up Permira’s new presence in the Nordic region, working alongside the newly appointed Ole Oftedal, who joins as an industrial partner.
MidOcean Capital, the newly established private equity group which last week acquired a E1.5bn portfolio of late stage investments from Deutsche Bank, is to manage the remaining assets owned by Morgan Grenfell’s Fund IV, valued at E1bn.
The UK private equity house is aiming for a £175m final close for its third fund targeting UK mid-market opportunities.
UK VCs back UDEX; Super Dimension lands $13m third round; Renovo adds to second round financing; Novartis, Nextech back Genetics acquisition; Novartis, Nextech back Genetics acquisition; Private Equity Investor exits Okena; AXA PE takes Planisware minority stake
The French private equity house has come close to exceeding the target for its third mid-market fund.
The Japanese venture firm has announced the second cutback from one of its VC funds, the fifteenth reduction of its kind since the beginning of 2002.
The Los Angeles-based firm has exceeded its original $1.5bn target for its fourth mid-market fund.